Ignite Creation Date:
2025-12-24 @ 5:04 PM
Ignite Modification Date:
2026-04-11 @ 12:58 AM
Study NCT ID:
NCT00104650
Status:
COMPLETED
Last Update Posted:
2011-01-24
First Post:
2005-03-03
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study of AMG 162 in Subjects With Advanced Cancer Currently Being Treated With Intravenous (IV) Bisphosphonates
Sponsor:
Amgen
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
20040114
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Global Development Leader
Old Organization:
Amgen Inc.